4 assets in Fanconi Anemia Complementation Group A

Therapeutic assets addressing Fanconi Anemia Complementation Group A, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Abiraterone Fanconi Anemia Complementation Group A	Qian Qin	P2	CCC (53)
Docetaxel Fanconi Anemia Complementation Group A	Qian Qin	P2	CCC (53)
Niraparib Fanconi Anemia Complementation Group A	Qian Qin	P2	CCC (53)
Prednisone Fanconi Anemia Complementation Group A	Qian Qin	P2	CCC (53)